ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Propensity Matched Analysis of Death and Non-favorable Discharge Among Hospitalized Transplant Recipients with COVID-19

J. T. Swan1, E. Rizk2, S. L. Jones1, N. Nwana1, J. C. Nicolas1, A. Tran1, T. Nisar1, T. Menser1, S. G. Yi2, L. W. Moore1, A. O. Gaber2, R. J. Knight2

1Houston Methodist Research Institute, Houston, TX, 2Houston Methodist Hospital, Houston, TX

Meeting: 2021 American Transplant Congress

Abstract number: 123

Keywords: Infection, Inflammation, Mortality, Outcome

Topic: Clinical Science » Infectious Disease » All Infections (Excluding Kidney & Viral Hepatitis)

Session Information

Session Name: COVID-19 Session 2

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 6, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:50pm-4:55pm

Location: Virtual

*Purpose: This study compared death and non-favorable discharge following a hospital admission for Coronavirus Disease 2019 (COVID-19) management for patients with a history of solid organ transplant (SOT) vs without (control).

*Methods: All non-pregnant adults who tested positive with symptomatic or asymptomatic COVID-19 and were admitted at a multihospital health-system from March 17, 2020 through August 24, 2020 were eligible for the study. Patients were excluded if their first positive COVID-19 test occurred >7 days before admission (potentially resolved) or >7 days after admission (potentially nosocomial). Patients not taking immunosuppression immediately prior to COVID-19 diagnosis were excluded from the SOT group. Outcomes included death at 60 days after admission and non-favorable discharge (death or hospice). To adjust for confounding due to differences in baseline demographics, a propensity score was calculated using age, sex, race, body mass index, hypertension, diabetes mellitus, chronic kidney disease, underlying liver disease, month of hospital admission, and area deprivation index (a surrogate for socioeconomic status). The matched cohort was generated using 1:1 nearest neighbor matching without replacement. Outcomes were analyzed using logistic regression that accounted for matching.

*Results: Among 4,562 included patients (108 SOT recipients and 4,454 controls), 60-day death occurred in 17% SOT vs 10% control (P=0.033) and non-favorable discharge in 18% SOT vs 9% control (P=0.004). Among 214 matched patients (107 SOT recipients, 107 controls), 60-day death occurred in 17% SOT vs 9% control (OR=2.0, 95%CI=0.9 to 4.4, P=0.106) and non-favorable discharge in 18% SOT vs 9% control (OR=2.1, 95%CI=1.0 to 4.6, P=0.063). As expected, propensity matching reduced confounding due to differences in baseline characteristics (Table 1). Transplanted organs included kidney (n=64), liver (n=13), lung (n=12), history of >1 organ (n=13), and heart (n=5).

*Conclusions: Recipients of SOT had a greater risk of 60-day death and non-favorable discharge among hospitalized patients with COVID-19 using unadjusted analysis. Preliminary data from the propensity matched analysis reported similar magnitudes of association but did not find statistical significance. A larger study may be needed to clarify whether immune-suppressed SOT recipients have greater risk of death or non-favorable discharge from COVID-19.

Balance of selected covariates before and after matching
SOT before matching (n=108) Controls before matching (n=4,454) SOT after matching (n=107) Controls after matching (n=107)
Age, mean ± SD 56 ± 13 59 ± 17 56 ± 13 56 ± 17
Male gender, n (%) 61 (56%) 2,286 (51%) 61 (57%) 62 (58%)
BMI, mean ± SD 29 ± 6 32 ± 8 29 ± 6 30 ± 8
Chronic kidney disease, n (%) 68 (63%) 992 (22%) 67 (63%) 70 (65%)
Underlying liver disease, n (%) 5 (5%) 283 (6%) 5 (5%) 8 (7%)
Hypertension, n (%) 87 (81%) 2,827 (63%) 86 (80%) 89 (83%)
Diabetes mellitus, n (%) 85 (79%) 2,097 (47%) 84 (79%) 85 (79%)
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Swan JT, Rizk E, Jones SL, Nwana N, Nicolas JC, Tran A, Nisar T, Menser T, Yi SG, Moore LW, Gaber AO, Knight RJ. Propensity Matched Analysis of Death and Non-favorable Discharge Among Hospitalized Transplant Recipients with COVID-19 [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/propensity-matched-analysis-of-death-and-non-favorable-discharge-among-hospitalized-transplant-recipients-with-covid-19/. Accessed May 11, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences